Beard CJ - Search Results

1

Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer.

Yang DD, Mahal BA, Muralidhar V, Nezolosky MD, Vastola ME, Labe SA, Boldbaatar N, King MT, Martin NE, Orio PF 3rd, Beard CJ, Hoffman KE, Trinh QD, Spratt DE, Feng FY, Nguyen PL. Yang DD, et al. Among authors: beard cj. Eur Urol Focus. 2019 Jan;5(1):69-76. doi: 10.1016/j.euf.2017.05.011. Epub 2017 Jun 17. Eur Urol Focus. 2019. PMID: 28753811

2

Phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer.

Beard C, Buswell L, Rose MA, Noll L, Johnson D, Coleman CN. Beard C, et al. Int J Radiat Oncol Biol Phys. 1994 Jun 15;29(3):611-6. doi: 10.1016/0360-3016(94)90467-7. Int J Radiat Oncol Biol Phys. 1994. PMID: 7516321 Clinical Trial.

3

Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml.

D'Amico AV, Whittington R, Kaplan I, Beard C, Jiroutek M, Malkowicz SB, Wein A, Coleman CN. D'Amico AV, et al. Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1053-8. doi: 10.1016/s0360-3016(96)00633-5. Int J Radiat Oncol Biol Phys. 1997. PMID: 9169812 Free article.

4

Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV.

D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Tomaszewski JE, Wein A, Coleman CN. D'Amico AV, et al. Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):335-40. doi: 10.1016/s0360-3016(97)00320-9. Int J Radiat Oncol Biol Phys. 1997. PMID: 9308936 Free article.

5

Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter.

D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Wein A, Tomaszewski JE, Coleman CN. D'Amico AV, et al. Cancer. 1998 Jan 15;82(2):334-41. doi: 10.1002/(sici)1097-0142(19980115)82:2<342::aid-cncr14>3.0.co;2-z. Cancer. 1998. PMID: 9445191

6

Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.

D'Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Coleman CN. D'Amico AV, et al. Among authors: beard cj. J Clin Oncol. 1999 Jan;17(1):168-72. doi: 10.1200/JCO.1999.17.1.168. J Clin Oncol. 1999. PMID: 10458230

7

Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer.

D'Amico AV, Schultz D, Loffredo M, Dugal R, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA, Kantoff PW. D'Amico AV, et al. Among authors: beard cj. JAMA. 2000 Sep 13;284(10):1280-3. doi: 10.1001/jama.284.10.1280. JAMA. 2000. PMID: 10979115

8

Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer.

D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. D'Amico AV, et al. Among authors: beard cj. Mol Urol. 2000 Fall;4(3):171-5;discussion 177. Mol Urol. 2000. PMID: 11062371

9

Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis.

Hurwitz MD, Schnieder L, Manola J, Beard CJ, Kaplan ID, D'Amico AV. Hurwitz MD, et al. Among authors: beard cj. Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1106-10. doi: 10.1016/s0360-3016(02)02885-7. Int J Radiat Oncol Biol Phys. 2002. PMID: 12128108

10

Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate.

D'amico AV, Tempany CM, Schultz D, Cormack RA, Hurwitz M, Beard C, Albert M, Kooy H, Jolesz F, Richie JP. D'amico AV, et al. Urology. 2003 Dec;62(6):1063-7. doi: 10.1016/s0090-4295(03)00772-6. Urology. 2003. PMID: 14665356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters